MAGE1 Is Expressed by a Subset of Pancreatic Endocrine Neoplasms and Associated Lymph Node and Liver Metastases

International Journal of Gastrointestinal Cancer

Volumn 33, Issue 2-3, 2003, Pages 141-147

  Hansel, Donna E ^a,c   House, Michael G ^a   Ashfaq, Raheela ^b   Rahman, Ayman ^a   Yeo, Charles J ^a   Maitra, Anirban ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Gastrinoma; Insulinoma; Liver; Metastasis; Pancreas; Tumor

Indexed keywords

MELANOMA ANTIGEN 1;

ADULT; ANTIBODY LABELING; ARTICLE; CANCER SURVIVAL; CELL HETEROGENEITY; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENDOCRINE TUMOR; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABELING INDEX; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; PANCREATIC ENDOCRINE NEOPLASM; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN ISOLATION;

EID: 0347478261     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: 10.1385/ijgc:33:2-3:141     Document Type: Article

References (31)

1. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 2002;188:22-32.
2. Van den Eynde B, Hainaut P, Herin M, et al. Presence on a human melanoma of multiple antigens recognized by autologous CTL. Int J Cancer 1989;44:634-640.
3. van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991;254:1643-1647.
4. Traversari C, van der Bruggen P, Van den Eynde B, et al. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 1992;35:145-152.
5. Traversari C, van der Bruggen P, Luescher IF, et al. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 1992;176:1453-1457.
6. De Plaen E, Arden K, Traversari C, et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994;40:360-369.
7. Stone B, Schummer M, Paley PJ, et al. MAGE-F1, a novel ubiquitously expressed member of the MAGE superfamily. Gene 2001;267:173-182.
8. Pold M, Zhou J, Chen GL, Hall JM, Vescio RA, Berenson JR. Identification of a new, unorthodox member of the MAGE gene family. Genomics 1999;59:161-167.
9. Lucas S, De Plaen E, Boon T. MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: four new members of the MAGE family with tumor-specific expression. IntJ Cancer 2000;87:55-60.
10. Lucas S, Brasseur F, Boon T. A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells. Cancer Res 1999;59: 4100-4103.
11. Lucas S, De Smet C, Arden KC, et al. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res 1998;58: 743-752.
12. Jay P, Rougeulle C, Massacrier A, et al. The human necdin gene, NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region. Nat Genet 1997;17:357-361.
13. Gure AO, Stockert E, Arden KC, et al. CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis. Int J Cancer 2000;85:726-732.
14. Bolli M, Kocher T, Adamina M, et al. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma. Ann Surg 2002;236:785-793; discussion 793.
15. Kocher T, Zheng M, Bolli M, et al. Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study. Int J Cancer 2002; 100:702-705.
16. Zuber M, Spagnoli GC, Kocher T, et al. Heterogeneity of melanoma antigen-1 (MAGE-1) gene and protein expression in malignant melanoma. Eur Surg Res 1997;29: 403-410.
17. Fischer C, Gudat F, Stulz P, et al. High expression of MAGE-3 protein in squamous-cell lung carcinoma. Int J Cancer 1997;71:1119-1121.
18. Brasseur F, Marchand M, Vanwijck R, et al. Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. Int J Cancer 1992;52: 839-841.
19. Rimoldi D, Romero P, Carrel S. The human melanoma antigen-encoding gene, MAGE-1, is expressed by other tumour cells of neuroectodermal origin such as glioblastomas and neuroblastomas. Int J Cancer 1993;54:527-528.
20. Nonomura N, Imazu T, Harada Y, et al Molecular staging of testicular cancer using polymerase chain reaction of the testicular cancer-specific genes. Hinyokika Kiyo 1999;45: 593-597.
21. Mackensen A, Herbst B, Chen JL, et al. Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells. Int J Cancer 2000;86:385-392.
22. Bodey B, Siegel SE, Kaiser HE. MAGE-1, a cancer/testis-antigen, expression in childhood astrocytomas as an indicator of tumor progression. In Vivo 2002;16:583-588.
23. Jungbluth AA, Busam KJ, Kolb D, et al. Expression of MAGE-antigens in normal tissues and cancer. Int J Cancer 2000;85:460-465.
24. Moingeon P. Antitumor vaccines: conception, development and evaluation in humans. Ann Pharm Fr 2002;60:253-259.
25. Park JH, Kim CJ, Lee JH, Shin SH, Chung GH, Jang YS. Effective immunotherapy of cancer by DNA vaccination. Mol Cells 1999;9:384-391.
26. De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA 1996;93:7149-7153.
27. Serrano A, Garcia A, Abril E, Garrido F, Ruiz-Cabello F. Methylated CpG points identified within MAGE-1 promoter are involved in gene repression. Int J Cancer 1996; 68:464-470.
28. Schadendorf D, Fichmer I, Makki A, et al. Metastatic potential of human melanoma cells in nude mice-characterisation of phenotype, cytokine secretion and tumour-associated antigens. Br J Cancer 1996;74: 194-199.
29. Amar-Costesec A, Godelaine D, Stockert E, van der Bruggen P, Beaufay H, Chen YT. The tumor protein MAGE-1 is located in the cytosol of human melanoma cells. Biochem Biophys Res Commun 1994;204:710-715.
30. Sahin U, Tureci O, Schmitt H, et al. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl. Acad Sci USA 1995;92:11810-11813.
31. Reynolds SR, Zeleniuch-Jacquotte A, Shapiro RL, et al. Vaccine-induced CD8+ T-cell responses to MAGE-3 correlate with clinical outcome in patients with melanoma. Clin Cancer Res 2003;9:657-662.